In this issue:
Japanese guidelines for GPP
Adalimumab in Japanese patients with GPP
Moderate-to-severe psoriatic patients switched to adalimumab
Systemic therapy and biologics in patients with psoriasis and HIV
Subclinical enthesopathy of extensor digitorum tendon and fingernail changes
Skin clearance with ixekizumab: 3-year results from UNCOVER-3
Infliximab and risk of serious infection
Cumulative exposure to biological therapy and risk of cancer
Ixekizumab for genital psoriasis
Selective TYK2 inhibition in psoriasis
Tofacitinib for chronic plaque psoriasis
Please login below to download this issue (PDF)